Isolating/Expanding the Entire TIL Repertoire of Tumor-Reactive CD8 T Cells for Cell Therapy in H&N Cancer
New Horizons in Head and Neck Cancer Annual Meeting; 2022 September 22; San Diego, CA.
Abstract
This paper has been withdrawn.
New Horizons in Head and Neck Cancer Annual Meeting; 2022 September 22; San Diego, CA.
